Skip to main content
OpenTrials
Completed

NCT Number: NCT02636452

Cardiopulmonary Exercise Testing in Interstitial Lung Disease

In patients with Interstitial lung diseases (ILD) dyspnea is the most often symptom. Pulmonary lung function tests often do not Show the dyspnea. Aim of the study is to evaluate cardiopulmonary exercise testing concerning therapeutic Monitoring in ILD.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Interstitial Lung Disease Lung Diseases Lung Diseases, Interstitial Respiratory Tract Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Bethanien Hospital, Clinic for Pneumology and Allergology, Center for Sleep and Respiratory Medicine

Solingen, North Rhine-Westphalia, 42699, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • informed consent provided
  • ILD

Exclusion criteria

  • no informed consent
  • no ILD

Treatment and study plan

Cardiopulmonary exercise test

Other

Primary outcomes

  1. Alveolar-arterial oxygen partial pressure difference (AaDO2) in cardipulmonary exercise testing in ILD

    Time frame: quarterly, three years

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Wissenschaftliches Institut Bethanien e.V

Other

Collaborators

  • Roche Pharma AG

Registry information

Important dates

Study start
2013
Primary completion
2017
Study completion
2017
First posted
Dec 21, 2015
Registry last updated
Oct 29, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.